SCHEMBL265271

SCHEMBL265271

N#CC(c1ccc(F)cc1)N(CCO)Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.45
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
NPBWR1 P48145 1/20 0.43
MCHR1 Q99705 1/20 0.43
HPGD P15428 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
USP2 O75604 1/20 0.39
ALPG P10696 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.36
MAPK1 P28482 1/20 0.36
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ACKR3 P25106 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL195269 0.86 KMT2A (0.46) LMNAALDH1A1KDM4EGAANPSR1
SCHEMBL14653954 0.80 GAA (0.39) LMNAALDH1A1KDM4EGAANPSR1
SCHEMBL8190574 0.75 LMNA (0.41) LMNAALDH1A1KDM4ENPSR1KMT2A
SCHEMBL8190573 0.75 LMNA (0.41) LMNAALDH1A1KDM4ENPSR1KMT2A
SCHEMBL263894 0.75 GAA (0.42) LMNAALDH1A1KDM4EGAANPSR1
SCHEMBL27966619 0.73 KMT2A (0.47) LMNAALDH1A1KDM4EGAANPSR1
Hydrochloric Acid SCHEMBL5847443 0.70 LMNA (0.54) LMNAALDH1A1KDM4EGAANPSR1
SCHEMBL13891162 0.69 HTT (0.50) LMNAALDH1A1KDM4EGAAKMT2A
SCHEMBL13891221 0.69 HTT (0.50) LMNAALDH1A1KDM4EGAAKMT2A
SCHEMBL27847954 0.69 KMT2A (0.44) LMNAALDH1A1KDM4EGAANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133994-B2 Preparation of aprepitant DR. REDDY'S LABORATORIES LTD. (IN) 2012-03-13 US disclosed
US-8133994-B2 Preparation of aprepitant DR. REDDY'S LABORATORIES LTD. (IN) 2012-03-13 US disclosed
US-8133994-B2 Preparation of aprepitant DR. REDDY'S LABORATORIES LTD. (IN) 2012-03-13 US disclosed
US-20110094321-A1 PREPARATION OF APREPITANT DR. REDDY'S LABORATORIES LIMITED (IN) 2011-04-28 US disclosed
US-20110094321-A1 PREPARATION OF APREPITANT DR. REDDY'S LABORATORIES LIMITED (IN) 2011-04-28 US disclosed
US-20110094321-A1 PREPARATION OF APREPITANT DR. REDDY'S LABORATORIES LIMITED (IN) 2011-04-28 US disclosed
EP-1942734-A2 PREPARATION OF APREPITANT Dr. Reddy's Laboratories Ltd. (IN) 2008-07-16 EP disclosed
WO-2007044829-A2 PREPARATION OF APREPITANT DR. REDDY'S LABORATORIES LTD. (IN) 2007-04-19 WO disclosed
WO-2007044829-A2 PREPARATION OF APREPITANT DR. REDDY'S LABORATORIES LTD. (IN) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110094321-A1 PREPARATION OF APREPITANT KIT, CPA3, CMA1 LMNA 2232/4885ALDH1A1 456/4885KDM4E 2494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.